Joseph FCA - Synairgen Plc CFO Director
SNG Stock | 0.90 0.06 6.25% |
Director
Joseph FCA is CFO Director of Synairgen plc
Age | 45 |
Address | Mailpoint 810, Southampton, United Kingdom, SO16 6YD |
Phone | 44 23 8051 2800 |
Web | https://www.synairgen.com |
Synairgen Plc Management Efficiency
The company has return on total asset (ROA) of (0.3058) % which means that it has lost $0.3058 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4886) %, meaning that it generated substantial loss on money invested by shareholders. Synairgen Plc's management efficiency ratios could be used to measure how well Synairgen Plc manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Non Current Assets Total is expected to grow to about 158 K, whereas Total Assets are forecasted to decline to about 12.7 M.Similar Executives
Showing other executives | DIRECTOR Age | ||
Lesley FCA | MyHealthChecked Plc | 67 | |
Syed Iqbal | British American Tobacco | 52 | |
MRICS BSc | Primary Health Properties | N/A | |
Paul Lageweg | British American Tobacco | 54 | |
Tadeu Marroco | British American Tobacco | 59 | |
David Austin | Primary Health Properties | N/A | |
Helena Sderberg | Coor Service Management | 58 | |
Andreas Engdahl | Coor Service Management | 47 | |
Jesse Putzel | Primary Health Properties | N/A | |
Paul McCrory | British American Tobacco | 53 | |
Nicholas Edwards | MyHealthChecked Plc | 54 | |
James Barrett | British American Tobacco | 50 | |
Magdalena hrn | Coor Service Management | 59 | |
FRICS BSc | Primary Health Properties | N/A | |
BA ACA | Primary Health Properties | 60 | |
Tony Coke | Primary Health Properties | N/A |
Management Performance
Return On Equity | -0.49 | ||||
Return On Asset | -0.31 |
Synairgen plc Leadership Team
Elected by the shareholders, the Synairgen Plc's board of directors comprises two types of representatives: Synairgen Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Synairgen. The board's role is to monitor Synairgen Plc's management team and ensure that shareholders' interests are well served. Synairgen Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Synairgen Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
Pr Djukanovic, CoFounder Board | ||
Gareth Walters, Chief Officer | ||
Richard Francis, Senior Quality | ||
Simon Esq, Company Secretary | ||
Jody Brookes, Senior Operations | ||
Joseph FCA, CFO Director | ||
Phillip Monk, Chief Board | ||
Victoria Tear, Head Laboratory | ||
Richard Marsden, MD CEO | ||
Marcin MD, Chief Officer | ||
Pr Davies, CoFounder Board | ||
MD CBE, NonExecutive CoFounder |
Synairgen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Synairgen Plc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.49 | ||||
Return On Asset | -0.31 | ||||
Current Valuation | 1.34 M | ||||
Shares Outstanding | 1.1 B | ||||
Shares Owned By Insiders | 0.57 % | ||||
Shares Owned By Institutions | 87.22 % | ||||
Price To Book | 1.04 X | ||||
Price To Sales | 759.00 X | ||||
Gross Profit | 105 K | ||||
EBITDA | (9.57 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Synairgen Stock
Synairgen Plc financial ratios help investors to determine whether Synairgen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Synairgen with respect to the benefits of owning Synairgen Plc security.